A Multicentric Experience on Living Donor Liver Transplantation in Coronavirus Disease 2019 Hotspots in India.
Joy VargheseSelvakumar MalleeswaranRajanikanth V PatchaEllango AppusamyPerumal KarnanDharmesh KapoorKota VenugopalChandhan Kumar KedarisettyBalbir SinghPrashantha S RaoRaghavendra Babu YalakantiRavi MohankaAnurag ShrimalVinayak NikamKaran KumarSunil D ShenviBhaskaran Pillai VenugopalNigel D HeatonPublished in: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2021)
As of August 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected more than 213 countries, leading to more than 18 million cases and 690,000 deaths. India is the second most affected country, with the majority of cases in metropolitan cities, such as Mumbai, New Delhi, Chennai, and Bengaluru. There is limited literature on the outcomes and safety of performing living donor liver transplantation (LDLT) in coronavirus disease 2019 (COVID-19) epicenters.